The social cost of rheumatoid arthritis in Italy: The results of an estimation exercise

Reumatismo

Volumn 65, Issue 6, 2013, Pages 271-277

  Turchetti, Giuseppe ^a   Bellelli, S ^a   Mosca, M ^b  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Cost of illness; Italy; Review; Rheumatoid arthritis; Social cost

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIRHEUMATIC AGENT;

ABSENTEEISM; ARTICLE; COST; COST BENEFIT ANALYSIS; COST OF ILLNESS; DAY HOSPITAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG COST; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; ITALY; MEDICAL COST; NON MEDICAL COST; PENSION; PRODUCTIVITY; REHABILITATION CARE; RHEUMATOID ARTHRITIS; SOCIAL COST; SOCIAL SECURITY; SYSTEMATIC REVIEW; WORK DISABILITY; ADULT; ARTHRITIS, RHEUMATOID; DISEASE COURSE; ECONOMICS; RISK ASSESSMENT;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; HEALTH CARE COSTS; HUMANS; ITALY; RISK ASSESSMENT;

EID: 84896450197     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2013.687     Document Type: Article

References (41)

1. Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2004; 22: 1-12S.
2. Stojakovich R, Vlajinac H, Palicobradovich D, Janosevic S, Adanja B. Prevalence of rheumatoid arthritis in Belgrade, Yugoslavia. Br J Rheumatol. 1998; 37: 729-32.
3. Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, et al. Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis. 2005; 64: 1427-30.
4. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology 2002; 41: 793-800.
5. Abdel-Nasser AM, Rasker JJ, Valkenburg HA. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum. 1997; 27: 123-40.
6. Cerra C, Ravasio R, Polcaro F. Il costo dell'Artrite Reumatoide: l'esperienza dell'ASL della Provincia di Pavia. Giorn It Health Technol Assess. 2009; 2: 111-7.
7. Cimmino MA, Parisi M, Moggiana G, Mela G, Accardo S. Prevalence of rheumatoid arthritis in Italy: the Chiavari study. Ann Rheum Dis. 1998; 57: 315-8.
8. Marotto D, Nieddu ME, Cossu A, Carcassi A. Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania's study. Reumatismo 2005; 57: 273-6.
9. Salaffi F, De Angelis R, Grassi W. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol. 2005; 23: 819-28.
10. Della Rossa A, Neri R, Talarico R, Doveri M, Consensi A, Salvadori S et al. Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy. Clin Rheumatol. 2010; 29: 71-81.
11. Osservatorio Sanità e Salute. Progetto di ricerca: costo sociale malattie reumatiche. Convegno "Malattie Reumatiche: disabilità, impatto sul lavoro e costi". Roma: Osservatorio Sanità e Salute 2008 Dec 4.
12. Lundkvist J, Kastang F, Kobelt G. The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur J Health Econ. 2008; 8: 49-60S.
13. Burton W, Morrison A, Maclean R, Ruderman E. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2006; 56: 18-27.
14. Young A, Dixey J, Kulinskaya E, Cox N, Davies P, Devlin J, et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis. 2002; 61: 335-40.
15. Quadrello T, Bevan S, McGee R. Fit For Work? Musculoskeletal disorders and the Italian labour market; 2009. Available from: http://www. fitforworkeurope. eu.
16. Turchetti G, Spadoni E, Geisler EE. Health technology assessment. Evaluation of biomedical innovative technologies. IEEE Eng Med Biol Mag. 2010; 29: 70-6.
17. Turchetti G, Scalone L, Della Casa Alberighi O, Mosca M, Montella S, Cortesi P, et al. The rationale of pharmacoeconomic analysis in rheumatologic indications. Clin Exp Rheumatol. 2012; 30: 64-71S.
18. Cortesi PA, Scalone L, D'Angiolella L, Belisari A, Fusco F, Olivieri I, et al. Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis. Clin Exp Rheumatol. 2012; 30: 126-31S.
19. Trieste L, Palla I, Baldini C, Talarico R, D'Angiolella L, Mosca M, et al. Systemic vasculitis: how little we know about their societal and economic burden. Clin Exp Rheumatol. 2012; 30: 154-6S.
20. Kobelt G, Woronoff AS, Richard B, Peeters P, Sany J. Disease status, costs and quality of life of patients with rheumatoid arthritis in France: the ECO-PR Study. Joint Bone Spine 2008; 75: 408-15.
21. Trieste L, Palla I, Fusco F, Tani C, Baldini C, Mosca M, et al. The economic impact of gout: a systematic literature review. Clin Exp Rheumatol. 2012; 30: 145-8S.
22. Kirchhoff T, Ruof J, Mittendorf T, Rihl M, Bernateck M, Mau W, et al. Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings. Rheumatology 2011; 50: 756-61.
23. Palla I, Trieste L, Tani C, Talarico R, Cortesi P, Mosca M, et al. A systematic literature review of the economic impact of Ankylosing Spondylitis. Clin Exp Rheumatol. 2012; 30: 136-41S.
24. Wolfe F, Michaud K. Out-of-pocket expenses and their burden in patients with rheumatoid arthritis. Arthritis Rheum. 2009; 61: 1563-70.
25. Turchetti G, Yazdany J, Palla I, Yelin E, Mosca M. SLE and the economic perspective: a systematic literature review and points to consider. Clin Exp Rheumatol. 2012; 30: 116-22S.
26. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press 2005.
27. Furneri G, Mantovani LG, Belisari A, Mosca M, Cristiani M, Bellelli S, et al. Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis. Clin Exp Rheumatol. 2012; 30: 70-82S.
28. Systematic Reviews: CRD's guidance for undertaking systematic reviews in health care. Centre for Reviews and Dissemination; 2009 Jan. Available from: http://www. york. ac. uk/inst/crd/SysRev/!SSL!/WebHelp/SysRev3. htm Accessed: 2013 July 22.
29. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from: http://www. cochrane-handbook. org Accessed: 2013 July 22.
30. ISTAT. Bilancio demografico anno 2011. Demografia in cifre. Available from: http://demo. istat. it/Accessed: 2012 Nov 15.
31. Regione Toscana. Bollettino Ufficiale della Regione Toscana DGR 1184 29 Dicembre 2008 Parte Seconda n. 2 del 14 gennaio 2009. Available from: http://www. regione. toscana. it/burt Accessed: 2012 Nov 15.
32. Ciocci A, Buratti L, Coari G, Di Franco M, Iagnocco AM, Mauceri MT, et al. Artrite reumatoide: stima della frequenza dei ricoveri e valutazione dei costi della malattia. Reumatismo 2001; 53: 215-22.
33. Commissione Permanente (12a Igiene e Sanità) del Senato della Repubblica Italiana. Indagine conoscitiva sulle malattie ad andamento degenerativo di particolare rilevanza sociale, con specifico riguardo al tumore alla mammella, alle malattie reumatiche croniche ed alla sindrome HIV 2011. Available from: http://www. senato. it/Accessed: 2012 Nov 15.
34. INPS. Rapporto annuale 2009. Available from: http://www. inps. it/Accessed: 2012 Nov 15.
35. ISTAT. Rilevazione sulle forze lavoro 2011. Available from: http://www. istat. it/it/archivio/8263 Accessed: 2012 Nov 15.
36. Leardini G, Salaffi F, Montanelli R, Gerzeli S, Canesi B. A multi-center cost-of illness study on rheumatoid arthritis in Italy. Clin Exp Rheumatol. 2002; 20: 505-15.
37. ISTAT. Lavoro e retribuzioni 2008. Available from: http://www. istat. it/Accessed: 2012 Nov 15.
38. Censis, ANMAR, SIR. Un percorso ad ostacoli, primo rapporto sociale sull'artrite reumatoide 2008. Available from: http://www. anmar-italia. it/Accessed: 2013 July 22.
39. Cicchetti A, Ruggeri M, Gori F. Quanto costa la reumatologia. Il Sole24Ore Sanità 2010; 36: 30.
40. ISTAT. Public expenditure on health 2013. Available from: http://noi-italia2013en. istat. it/index. php?id=53 Accessed: 2013 July 22.
41. OECD. OECD. Stat 2013. Available from: http://stats. oecd. org/Accessed: 2013 July 22.